US4547359A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Divisible pharmaceutical tablet with delayed active ingredient release
Assignee: Boehringer Ingelheim GmbH
•
Filing: 1984-03-21
•
Granted: 1985-10-15
•
Expires: 2004-03-21
Abstract
Abstract A novel divisible delayed release pharmaceutical tablet, wherein the rate of release of active ingredient is independent of the size and nature of the total surface area, and the fragments of which have the same characteristics of release of active ingredient as the undivided tablet.
Inventors
- 👤 Bernd Zierenberg
- 👤 Arun R. Gupte
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 05:08
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027; A61K9/2072; A61K9/2077; A61K9/14; A61K9/141; A61K9/146
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
100 words
A pharmaceutical delayed active ingredient release tablet wherein the rate of release of active ingredient from any fragment thereof is the same and independent of the size and nature of the total surface area, consisting of a compressed tablet-making composition comprising finely divided active ingredient-containing emulsion-polymerized polyacrylate material having a particle size between 10 and 500 microns ground below the glass temperature without the excipients, conventional tablet-making excipients and active ingredient with a molecular weight of up to about 500 and a diffusion coefficient of about 10 -5 to 10 -7 cm 2 /hr molecularly dispersed in said polyacrylate material.
Claim 2
Dependent Claim
100 words
A pharmaceutical delayed active ingredient release tablet wherein the rate of release of active ingredient from any fragment thereof is the same and independent of the size and nature of the total surface area, consisting of a compressed tablet-making composition comprising finely divided active ingredient-containing emulsion-polymerized polyacrylate material having a particle size between 10 and 500 microns ground below the glass temperature without the excipients, conventional tablet-making excipients and active ingredient with a molecular weight of up to about 500 and a diffusion coefficient of about 10 -5 to 10 -7 cm 2 /hr molecularly dispersed in said polyacrylate material.
Claim 3
Dependent Claim
31 words
A pharmaceutical tablet of claim 1, where said polyacrylate material is a copolymer of methyl and/or ethyl esters of acrylic and methacrylic acid having an average molecular weight of about 800,000.
Claim 4
Dependent Claim
20 words
A pharmaceutical tablet of claim 2, where ethylene polymers with acidic or basic groups are admixed with the polyacrylate material.
Claim 5
Dependent Claim
19 words
A pharmaceutical tablet of claim 1, where said active ingredient is present in an amount up to 50 milligrams.
References Cited (Backward Citations)
US2987445A
Cited
US3087860A
Cited
US3390050A
Cited
US3520970A
Cited
US3608063A
Cited
US3629392A
Cited
US3775537A
Cited
US4013820A
Cited
US4083969A
Cited
US4248855A
Cited
US4391797A
Cited
US4223006A
Cited
US4152414A
Cited
US4152415A
Cited
US4152413A
Cited
US4351825A
Cited
US4343789A
Cited
US4404183A
Cited
US4353887A
Cited
US4357312A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-10-14 | 1989-04-15 | 1989-10-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-10-14 | 1993-04-15 | 1993-10-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-10-14 | 1997-04-15 | 1997-10-15 | $7700.00 | Window Closed / Lapsed |